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Abstract: Vitreomacular traction (VMT) is a condition characterized by
an incomplete posterior vitreous detachment resulting in traction on
the macula and decreased visual acuity. The process of vitreomacular
traction can lead to a number of maculopathies including cystoid
macular edema, epiretinal membranes, and macular holes. VMT is more
common in patients over 40 years of age; however no population-based
studies documenting the prevalence of VMT in this age group has been
published. Purpose: The current study was undertaken to evaluate the
prevalence of vitreomacular traction syndrome in the population aged
above 40. Clinical examination does not adequately illustrate the extent
of vitreomacular adhesion; therefore, Optical Coherence Tomography
(OCT) was used to determine the presence of VMT. High-definition OCT
has provided new insight into vitreomacular traction syndrome by
allowing for better visualization of the tractional forces at the
vitreoretinal interface. This investigation will analyze the vitreomacular
interface with regard to VMT in correlation to age through use of the
Spectral Domain OCT.
Methods: One hundred and thirty-one eyes of 67 patients (36
females/31 males) were examined by optical coherence tomography
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(OCT). OCT was performed to obtain high-resolution cross-sectional
images of the vitreoretinal interface in the posterior fundus.
Results: The status of the posterior vitreoretinal interface was
evaluated as follows; (1) Intact Vitreous- No posterior vitreous
abnormality is depicted on OCT. (2) Vitreomacular
adhesion/incomplete PVD- the posterior vitreous is partially attached
and can be seen in contact with the macula on OCT. (3) Vitreomacular
traction- the posterior vitreous is partially adhered to the inner retina
resulting in distortion of the retinal architecture. (4) Complete posterior
vitreous detachment, indicating no contact between the vitreous and
retina.
Conclusion: OCT results found no vitreous abnormality in 39.7% of all
eyes; PVD in 6.87% of eyes, VMA in 51.1% of eyes, and VMT in 2.29% of
eyes. Age was a significant risk factor to the development of VMT, while
gender was not. As age increases, the probability of having VMT
increases by 1.2%.

Due to the association between vitreomacular traction and a variety of
maculopathies, recognition and diagnosis of this entity is crucial. High
definition OCT has allowed for outstanding visualization of the
4
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vitreomacular interface, which has allowed for a better understanding
of this entity.

INTRODUCTION

Anatomy of the Vitreous

In order to fully understand a disease of the retina, vitreous and vitreoretinal interface, an appreciation for the posterior anatomy of the eye is
essential. The posterior portion of the eye is comprised of the vitreous,
uvea (ciliary body), retina, sclera and choroid. Vitreomacular traction
syndrome affects the retina and vitreous, thus a brief review of the
anatomy of these two structures will be discussed.

The vitreous humor is situated between the lens and the retina, and is a
clear, highly hydrated gel.1 The vitreous occupies a volume of
approximately 4 ml, weighs approximately 4 grams, and is responsible
for four-fifths of the globe volume.1 Water makes up 98% of the vitreous
humor, with its gel-like structure compromised of glycosaminoglycans
(hyaluronan and chondroitin sulfate) and a network of collagen fibrils. 25

